Geographically widespread plant medicine, its persistent risks, and their impact on all sections of society, during historical time periods are appraised Risks associated with plant medicine were political, economic, logistic, financial, military, medical, religious and racial. Included in the appraisal of risks, are their causes, consequences, measurement and management.
Contents
Introduction
Plant Medicine Risks
Stakeholders at Risk
Products at Risk
Risk Indicators
Causes of Risks
Risk Measurement and Assessment
Risk Characteristics
Intrinsic Risk Resistance
Managing Risks
Conclusions
Objectives and Topics
The work examines the complex historical network of plant medicine, focusing on the various medical, logistic, and financial risks encountered by stakeholders throughout history. The central research question explores how practitioners, patients, and traders identified, managed, and mitigated these risks across different geographical and temporal contexts.
- Evolution of risk identification in plant medicine.
- Economic forces affecting supply, demand, and pricing.
- Role of information transmission and quality control.
- Strategies for risk mitigation by different stakeholder groups.
- Historical impact of regulation, social factors, and environment on medicinal flora availability.
Excerpt from the Book
INTRODUCTION
Historically plant, or herbal, medicine, also known as medical botany and phytomedicine, was a complex, ubiquitous network of interacting variable elements and crossovers. Christopher p245. More popular than its present day successor, systems were driven by patients’ variable demands for treatment, and also entrepreneurial venturers. The Economist p80. Influencing treatment were risks of product availability, patient acceptability, provider attributes, financial considerations and external interference. Maddocks p148.
Plant medicine was practised by ancient civilisations in Mesopotamia, China, Greece and Rome, in the Arab world, then in medieval and early modern Europe as well as in the New World. In eighteenth century England, surgeon-apothecaries’ preparations were often herbal. Lane p46. Herbalism may have been the core of alternative medicine but, in nineteenth century Latin America, and possibly at other times, in other places, spiritism, magic and divination collectively constituted popular medicine. Birn p249. Bivins p580. Early Records and Extent of Plant Medicine, Figure 1, refers.
The literature shows the complexity of plant medicine history, the scope for, and response to, its medical, logistic, financial and other risks. In many parts of the world, and throughout its long history, treating all social classes, age groups and genders, paid professionals, and unpaid amateurs, occasionally with parts of trees, but more routinely with preferred, and substitute, whole or parts of plants, wild and cultivated, raw or processed, singly, or in compounds, (sometimes with mineral, animal or vegetable supplements and using ancillary products), found locally, or imported, by entrepreneurial traders, probably distributed by intermediaries; used by practitioners, whose abilities varied, full-time specialists (possibly members of an association), or part-time jobbers, utilising written and oral, longstanding and contemporary information, case histories or their own on-the-spot diagnoses, as they recognised, or failed to recognise, foreseeable and unforeseeable risk-generating situations, varying in frequency, repeatability, duration, magnitude and causation.
Summary of Chapters
Introduction: Provides an overview of plant medicine as a complex historical network driven by patient demand and entrepreneurial ventures, highlighting the inherent risks involved.
Plant Medicine Risks: Categorizes the diverse range of risks, including medical, logistic, financial, and environmental, faced by those involved in the plant medicine system.
Stakeholders at Risk: Analyzes the different groups within the plant medicine network, from patients and gatherers to traders and physicians, and their varying exposure to risks.
Products at Risk: Discusses the vulnerabilities associated with the supply and quality of medicinal flora, supplements, and ancillary products.
Risk Indicators: Identifies the signals used historically to recognize impending risks, such as supply shortages, price surges, and external events like epidemics.
Causes of Risks: Examines the natural and human-originated causes of risk, including environmental changes, tectonic activity, and socioeconomic pressures.
Risk Measurement and Assessment: Explores how stakeholders historically measured and evaluated risks to make decisions about their ventures and treatment practices.
Risk Characteristics: Details the intrinsic properties of risks, such as complexity, unpredictability, variability, and the way risks propagate through networks.
Intrinsic Risk Resistance: Identifies attributes such as patronage and established connectivity that helped plant medicine persist despite external pressures.
Managing Risks: Reviews the portfolio of pro-active and reactive techniques used to manage risks, including standardization, regulation, and information dissemination.
Conclusions: Summarizes the dynamic nature of risks in plant medicine and the importance of management techniques in navigating the diverse challenges faced by stakeholders.
Keywords
Plant medicine, Phytomedicine, Historical risk management, Medical botany, Stakeholder networks, Supply chain, Medicinal flora, Economic forces, Information quality, Risk mitigation, Apothecaries, Practitioners, Trade networks, Healthcare history, Risk indicators.
Frequently Asked Questions
What is the primary focus of this work?
The work provides a comprehensive historical analysis of the risks inherent in plant medicine systems and how various stakeholders identified and managed these risks over centuries.
What are the main categories of risk discussed?
The research identifies medical, logistic, financial, fiscal, military, demographic, psychological, and environmental risks as the primary clusters affecting the plant medicine network.
How is the term "stakeholder" defined in this context?
Stakeholders are defined as any individuals or groups with an interest in plant medicine, including patients, gatherers, apothecaries, physicians, traders, investors, and information providers.
What research methods were utilized?
The author analyzes historical records, literature, and accounts to reconstruct the risk management practices of the past, utilizing case studies and comparative historical perspectives.
What role does information transmission play in this history?
Information quality and accuracy were critical; errors in herbal descriptions, translations, or oral communication could lead to medical risks and consequential reputation loss for practitioners.
What characterizes the management of risks in plant medicine?
Management involved a portfolio of techniques ranging from pro-active strategies like cultivation and library building to reactive measures such as litigation and insurance.
How did economic forces influence the availability of plant medicines?
Supply and demand fluctuations, taxation, and trade wars created complex financial risks, often compelling practitioners to find substitutes or diversify their businesses.
How significant was the role of the apothecary?
Apothecaries served as a central hub in the supply chain, often bridging the gap between raw product provision and end-user treatment, and were key participants in various risk management strategies.
- Arbeit zitieren
- Dr BA (Honours), MSc, PhD Denys Hill (Autor:in), 2019, Risk in Plant Medicine History, München, GRIN Verlag, https://www.grin.com/document/492434
